• Tuesday, Oct 20, 2020
  • Last Update : 08:01 pm

EU seals second Covid-19 vaccine deal as WHO scheme deadline looms

  • Published at 06:49 pm September 18th, 2020
Vaccine-Coronavirus-Covid
File photo: Small bottles labelled with a 'Vaccine Covid-19' sticker and a medical syringe are seen in this illustration taken April 10, 2020 Reuters

Sanofi and GSK started clinical trials of their vaccine this month and aim to reach the final testing stage by December

The European Union has agreed to buy a potential Covid-19 vaccine from Sanofi and GSK in its second such deal to secure supplies, as a deadline for joining the World Health Organization's (WHO) vaccine purchase programme looms.

The deal will see the French and British drugmakers, which have teamed up to manufacture a recombinant protein-based vaccine they hope to get approved next year, provide the EU with up to 300 million doses.

Friday's agreement confirms an announcement made on July 31 by the two companies and follows an earlier deal between the EU and AstraZeneca for up to 400 million shots.

In return for the right to the doses, the European Commission will finance part of the upfront costs faced by vaccine producers. The vaccine doses themselves will be bought by EU countries.

The latest deal comes on deadline day for members of the WHO to join its Covax scheme, which aims to buy Covid-19 vaccines and ensure immunisations are fairly and efficiently distributed.

So far, 92 lower-income nations are seeking assistance via Covax, part of the WHO's Act Accelerator to boost development of vaccines, therapeutics and diagnostics to combat the pandemic.

Some 80 higher-income nations have expressed interest, but many have yet to join as they scramble to secure supplies separately.

France will provide funding for the initiative but will not source shots through it, a health ministry official said on Thursday, after Paris decided to be part of a joint scheme arranged through the EU.

There is currently no internationally-approved vaccine for Covid-19, the illness caused by the new coronavirus, which has claimed more than 946,000 lives and derailed the world economy.

For Sanofi and GSK, the deal follows a $2.1 billion agreement with the United States in July for 100 million doses, with an option for Washington to purchase an additional 500 million, as well as a UK deal for 60 million doses.

Sanofi and GSK started clinical trials of their vaccine this month and aim to reach the final testing stage by December.

The vaccine candidate uses the same recombinant protein-based technology as one of Sanofi's seasonal influenza vaccines. It will be coupled with an adjuvant, a substance that acts as a booster to the vaccine, made by GSK.

The two companies are scaling up manufacturing to be ready to produce up to one billion doses per year.

Sanofi is also working on another potential Covid-19 vaccine with US company Translate Bio, using a technology called mRNA.

53
52
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail